from Reuters: Health News https://ift.tt/2s4ng4Y
FDA approves BioMarin rare metabolic disorder drug, shares rise
(Reuters) - U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc's Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending shares of the biotechnology company up 3 percent after hours.
from Reuters: Health News https://ift.tt/2s4ng4Y
from Reuters: Health News https://ift.tt/2s4ng4Y
Subscribe to:
Post Comments (Atom)
-
Sometimes the best paleo snacks are frozen ones. Wether it’s because of hot weather, after a workout or just because you want to feel light ...
-
Let’s be honest: we put our hair through a lot — from heat styling to dye jobs and loading it with product. So, it’s about time our strands...
-
Paleo Grubs Paleo Grubs - She told me that she adds molasses to give it that specific taste. She brought the bottle out for me to dip my ...
No comments:
Post a Comment